STRATEC BIOMEDICAL SYSTEMS AG : Warburg Research gives a Buy rating
Already positive, the research from Warburg Research and its analyst Michael Heider still consider the stock as a Buy opportunity. The target price is unchanged and still at EUR 80. | April 28, 2023